Enzo Life Sciences, Inc.
Patent owner in reexamination·4 ex parte reexams
Enzo Life Sciences, Inc.'s patents have been the subject of 4 USPTO ex parte reexaminations, with 1 currently open. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
219
122
125
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (4)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/015,749 | Dec 16, 2025 | 7,064,197 | SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS | — | Open |
| 90/015,080 | Jul 26, 2022 | 7,064,197 | SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS | — | Closed |
| 90/014,270 | Feb 26, 2019 | 7,064,197 | System, Array and Non-Porous Solid Support Comprising Fixed or Immobilized Nucleic Acids | — | Closed |
| 90/014,272 | Feb 26, 2019 | 7,064,197 | SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS | — | Closed |
See the full reexam picture for Enzo Life Sciences, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.